Regression of glucometabolic complications after correction of aldosterone excess should be confirmed by larger studies, and the influence on the natural history of PA of agents potentially able to correct insulin resistance and/or dyslipidemia should be explored. Further studies are warranted to clarify the issue of specific metabolic dysfunctions in PA.
Metabolic syndrome and primary aldosteronism: time for reappraisal?
FALLO, FRANCESCO;SONINO, NICOLETTA
2010
Abstract
Regression of glucometabolic complications after correction of aldosterone excess should be confirmed by larger studies, and the influence on the natural history of PA of agents potentially able to correct insulin resistance and/or dyslipidemia should be explored. Further studies are warranted to clarify the issue of specific metabolic dysfunctions in PA.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JHUMHYP.pdf
Accesso riservato
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso privato - non pubblico
Dimensione
104.43 kB
Formato
Adobe PDF
|
104.43 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
